Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.
Shastri, Yogesh M
Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study. [electronic resource] - Clinical laboratory 2008 - 389-90 p. digital
Publication Type: Comparative Study; Journal Article
1433-6510
Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers--analysis
Enzyme-Linked Immunosorbent Assay
Feces--chemistry
Female
Humans
Inflammatory Bowel Diseases--diagnosis
Leukocyte L1 Antigen Complex--analysis
Male
Middle Aged
Prospective Studies
Pyruvate Kinase--analysis
Sensitivity and Specificity
Young Adult
Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study. [electronic resource] - Clinical laboratory 2008 - 389-90 p. digital
Publication Type: Comparative Study; Journal Article
1433-6510
Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers--analysis
Enzyme-Linked Immunosorbent Assay
Feces--chemistry
Female
Humans
Inflammatory Bowel Diseases--diagnosis
Leukocyte L1 Antigen Complex--analysis
Male
Middle Aged
Prospective Studies
Pyruvate Kinase--analysis
Sensitivity and Specificity
Young Adult